Suboh Alkhushayni, Du’a Al-zaleq, Luwis Andradi, Patrick Flynn
{"title":"不同机器学习算法在皮肤癌和黑色素瘤检测中的应用及其相关性能","authors":"Suboh Alkhushayni, Du’a Al-zaleq, Luwis Andradi, Patrick Flynn","doi":"10.1155/2022/2839162","DOIUrl":null,"url":null,"abstract":"Skin cancer, and its less common form melanoma, is a disease affecting a wide variety of people. Since it is usually detected initially by visual inspection, it makes for a good candidate for the application of machine learning. With early detection being key to good outcomes, any method that can enhance the diagnostic accuracy of dermatologists and oncologists is of significant interest. When comparing different existing implementations of machine learning against public datasets and several we seek to create, we attempted to create a more accurate model that can be readily adapted to use in clinical settings. We tested combinations of models, including convolutional neural networks (CNNs), and various layers of data manipulation, such as the application of Gaussian functions and trimming of images to improve accuracy. We also created more traditional data models, including support vector classification, K-nearest neighbor, Naïve Bayes, random forest, and gradient boosting algorithms, and compared them to the CNN-based models we had created. Results had indicated that CNN-based algorithms significantly outperformed other data models we had created. Partial results of this work were presented at the CSET Presentations for Research Month at the Minnesota State University, Mankato.","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":"3 1","pages":""},"PeriodicalIF":1.2000,"publicationDate":"2022-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"The Application of Differing Machine Learning Algorithms and Their Related Performance in Detecting Skin Cancers and Melanomas\",\"authors\":\"Suboh Alkhushayni, Du’a Al-zaleq, Luwis Andradi, Patrick Flynn\",\"doi\":\"10.1155/2022/2839162\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Skin cancer, and its less common form melanoma, is a disease affecting a wide variety of people. Since it is usually detected initially by visual inspection, it makes for a good candidate for the application of machine learning. With early detection being key to good outcomes, any method that can enhance the diagnostic accuracy of dermatologists and oncologists is of significant interest. When comparing different existing implementations of machine learning against public datasets and several we seek to create, we attempted to create a more accurate model that can be readily adapted to use in clinical settings. We tested combinations of models, including convolutional neural networks (CNNs), and various layers of data manipulation, such as the application of Gaussian functions and trimming of images to improve accuracy. We also created more traditional data models, including support vector classification, K-nearest neighbor, Naïve Bayes, random forest, and gradient boosting algorithms, and compared them to the CNN-based models we had created. Results had indicated that CNN-based algorithms significantly outperformed other data models we had created. Partial results of this work were presented at the CSET Presentations for Research Month at the Minnesota State University, Mankato.\",\"PeriodicalId\":17172,\"journal\":{\"name\":\"Journal of Skin Cancer\",\"volume\":\"3 1\",\"pages\":\"\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2022-05-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Skin Cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2022/2839162\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Skin Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2022/2839162","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
The Application of Differing Machine Learning Algorithms and Their Related Performance in Detecting Skin Cancers and Melanomas
Skin cancer, and its less common form melanoma, is a disease affecting a wide variety of people. Since it is usually detected initially by visual inspection, it makes for a good candidate for the application of machine learning. With early detection being key to good outcomes, any method that can enhance the diagnostic accuracy of dermatologists and oncologists is of significant interest. When comparing different existing implementations of machine learning against public datasets and several we seek to create, we attempted to create a more accurate model that can be readily adapted to use in clinical settings. We tested combinations of models, including convolutional neural networks (CNNs), and various layers of data manipulation, such as the application of Gaussian functions and trimming of images to improve accuracy. We also created more traditional data models, including support vector classification, K-nearest neighbor, Naïve Bayes, random forest, and gradient boosting algorithms, and compared them to the CNN-based models we had created. Results had indicated that CNN-based algorithms significantly outperformed other data models we had created. Partial results of this work were presented at the CSET Presentations for Research Month at the Minnesota State University, Mankato.
期刊介绍:
Journal of Skin Cancer is a peer-reviewed, Open Access journal that publishes clinical and translational research on the detection, diagnosis, prevention, and treatment of skin malignancies. The journal encourages the submission of original research articles, review articles, and clinical studies related to pathology, prognostic indicators and biomarkers, novel therapies, as well as drug sensitivity and resistance.